
Friday, June 14, 2024 3:47:10 PM
And yes - the tumor shrinkage and disease regression data will be available, if not collated and easily analyzable within weeks for each patient. Anecdotal data will be available, but getting the data organized enough to critically analyze is going to take time. If whatever CRO or deep pockets supporter is on the ball and organized, that is still likely to take months post the trial being filled. Again - it's going to take somebody organized and that will have money to throw at the problem to speed things up more than that.
I do think that a conditional approval for Multikine, based on beneficial tumor regression data, is possible by sometime in 2026 as well.
It's going to be an interesting ride here in the meantime.
Have a good weekend folks.
“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy
Recent CVM News
- CEL-SCI Announces Closing of Public Offering • Business Wire • 05/23/2025 08:05:00 PM
- CEL-SCI Announces Pricing of Public Offering • Business Wire • 05/22/2025 12:14:00 AM
- CEL-SCI Announces Proposed Public Offering • Business Wire • 05/21/2025 08:05:00 PM
- CEL-SCI’s Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia • Business Wire • 05/21/2025 12:00:00 PM
- CEL-SCI Announces Combination of Common Stock • Business Wire • 05/19/2025 06:40:00 PM
- CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results • Business Wire • 05/15/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:20:57 PM
- CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market • Business Wire • 04/23/2025 12:30:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (US) • 04/14/2025 02:15:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (Canada) • 04/14/2025 02:10:00 PM
- With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz • PR Newswire (US) • 04/14/2025 02:10:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2025 05:00:21 PM
- New Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses • Business Wire • 04/08/2025 01:51:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:51:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:49:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 01:46:47 PM
- CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients • Business Wire • 03/24/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2025 09:07:52 PM
- CEL-SCI Announces Closing of $2.5 Million Offering • Business Wire • 03/18/2025 08:05:00 PM
- CEL-SCI Announces Pricing of $2.5 Million Offering • Business Wire • 03/17/2025 07:24:00 PM
- CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine • Business Wire • 03/17/2025 12:00:00 PM
- CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial • Business Wire • 02/20/2025 01:00:00 PM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM
NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM
Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM